How should I evaluate and manage a patient presenting with fever, bilateral axillary pain radiating to the arms, and swelling of multiple joints?

Evaluation and Management of Fever with Bilateral Arm Pain and Systemic Joint Swelling

This presentation requires urgent evaluation for Still's disease (systemic juvenile idiopathic arthritis/adult-onset Still's disease) as the primary consideration, followed by systematic exclusion of infection and assessment for inflammatory arthritis including spondyloarthritis and rheumatoid arthritis.

Immediate Diagnostic Priorities

Rule Out Infection First

• Fever with systemic joint involvement mandates immediate exclusion of infectious etiologies before initiating immunosuppressive therapy 1, 2
• The main challenge is differentiating infectious from immune-inflammatory causes, which requires pattern recognition of clinical presentations and corresponding laboratory abnormalities 2
• Obtain blood cultures, complete infectious workup including viral serologies, and consider joint aspiration if any single joint appears disproportionately affected 1

Assess for High Disease Activity Features

If the patient exhibits high spiking fever, widespread polyarthritis, high pain levels (VAS >6-7/10), pericarditis, or elevated liver function tests with high serum ferritin, this indicates high disease activity requiring aggressive treatment 1

Essential Clinical Evaluation

Physical Examination Focus

• Perform focused examination to identify definite synovitis (soft tissue swelling around joints, not bony enlargement), which is the cornerstone of inflammatory arthritis diagnosis 3, 4
• Assess for symmetric involvement of small joints, particularly metacarpophalangeal joints, proximal interphalangeal joints, wrists, and metatarsophalangeal joints 4
• Evaluate for morning stiffness lasting >30-60 minutes, characteristic of inflammatory arthritis 4
• Document the number of swollen and tender joints, as this is an independent risk stratification factor 5

Pattern Recognition

• Fever with polyarthritis can represent Still's disease, peripheral spondyloarthritis, or early rheumatoid arthritis 6, 7
• Peripheral spondyloarthritis patients can present with fever and severe systemic inflammatory response mimicking infection, requiring hospitalization 6
• Various subgroups of spondyloarthritis can present with fever as initial manifestation, demonstrating higher systemic inflammation 7

Laboratory Workup

Baseline Studies

• Order complete blood count with differential, comprehensive metabolic panel, and urinalysis 3
• Obtain C-reactive protein (preferred over ESR as more reliable and not age-dependent) and erythrocyte sedimentation rate 4
• Check serum ferritin levels urgently, as markedly elevated ferritin with fever and polyarthritis strongly suggests Still's disease 1
• Monitor liver function tests closely, as elevated LFT with high ferritin may indicate impending macrophage activation syndrome 1

Autoimmune Serology

• Order rheumatoid factor (70% specificity, moderate sensitivity) and anti-citrullinated protein antibodies (90% specificity, 60% sensitivity) 4
• Consider HLA-B27 testing if spondyloarthritis is suspected, though febrile spondyloarthritis patients are less frequently HLA-B27 positive (52% vs 77% in non-febrile patients) 7

Imaging Studies

• Obtain bilateral hand, wrist, and foot X-rays to assess for erosions, periarticular osteopenia, and uniform joint space narrowing 3, 4
• Consider ultrasound with Power Doppler, which detects synovitis 2.18-fold more frequently than clinical examination 5
• If spondyloarthritis is suspected, obtain sacroiliac joint radiographs 7

Treatment Algorithm Based on Disease Activity

High Disease Activity (High Spiking Fever, Widespread Polyarthritis, Pericarditis, or Impending MAS)

Initiate high-dose glucocorticoids (≥1 mg/kg/day prednisone equivalent in adults, 2 mg/kg/day in children) intravenously then orally, combined with IL-1 or IL-6 inhibitors 1

• Anakinra is the preferred IL-1 inhibitor for patients with impending macrophage activation syndrome, often using high-dose anakinra (>4 mg/kg/day in children or 100 mg twice daily in adults) 1
• Begin glucocorticoid tapering as soon as fever resolves and active joints decrease by 50% 1

Low or Intermediate Disease Activity

Start IL-1 or IL-6 inhibitors with low-dose glucocorticoids (≤0.1 mg/kg/day prednisone equivalent in adults, 0.2 mg/kg/day in children) 1

Treatment Targets and Monitoring

• Target clinically inactive disease on low-dose glucocorticoids at 3 months, then clinically inactive disease off glucocorticoids at 6 months 1
• If these targets are not achieved, rotate between IL-1 and IL-6 inhibitors while continuing progressive glucocorticoid tapering 1
• Patients failing to achieve clinically inactive disease off glucocorticoids after IL-1/IL-6 inhibitor rotation are considered difficult-to-treat and require multidisciplinary discussion with Still's disease experts 1

Symptomatic Management While Establishing Diagnosis

Bridge Therapy

• Initiate NSAIDs such as naproxen 500 mg twice daily at minimum effective dose for shortest time possible 3, 4
• Consider short-term glucocorticoids (prednisone 5-10 mg daily) as bridge therapy for temporary relief while awaiting definitive diagnosis and DMARD effect 3, 4

Urgent Rheumatology Referral

Schedule rheumatology evaluation within 6 weeks of symptom onset, as early specialist evaluation and DMARD therapy prevents irreversible joint damage in up to 90% of patients 3, 4

• Forward all laboratory results and imaging studies to the specialist before the appointment 3, 4
• Patients with fever and arthritis have lower rates of early rheumatology referral (7.7% vs 59% in non-febrile patients), contributing to diagnostic delay 7

Critical Pitfalls to Avoid

Diagnostic Delays

• Do not dismiss fever as simply infectious without considering inflammatory rheumatic diseases 6, 7
• Febrile spondyloarthritis patients demonstrate severe systemic inflammatory response (leukocytosis, thrombocytosis, high ESR and CRP) that mimics infection, leading to extensive infectious workups and delayed diagnosis 6
• Mean diagnostic delay for axial spondyloarthritis presenting with fever is 9.3 years 8

Treatment Considerations

• Never initiate immunosuppressive therapy before ruling out infection 1, 2
• Patients with febrile inflammatory arthritis require higher rates of systemic steroid treatment (57.7% vs 11% in non-febrile patients) 7
• If Still's disease is confirmed, maintain IL-1 or IL-6 inhibitors for 3-6 months after achieving clinically inactive disease off glucocorticoids before considering tapering 1

Monitoring for Complications

• Watch for macrophage activation syndrome development at any time, which requires prompt treatment 1
• Monitor for major flares while in clinically inactive disease off glucocorticoids, which should be treated as if at disease onset 1